Molecular Devices Ltd

Activities: Manufacturing Analysis

Trending Articles

  1. NHS, MHRA and Medicines UK launch Project Revive to tackle medicine shortages NHS England, the MHRA and Medicines UK have launched Project Revive, a collaborative pilot designed to address critical medicines shortages by fast-tracking dormant...
  2. Isopod Rapid Cleanrooms: the ideal elite controlled environment pod solution for Life Sciences and Engineering start-ups The Guardtech Group’s quick-assembly cleanroom pods combine superior performance, build quality and cost-effectiveness to give new applications the perfect platform to get...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Delivering precision: why advanced therapies are redefining pharmaceutical logistics As advanced therapies narrow tolerances and personalise care, pharmaceutical logistics is being redefined as a precision-driven extension of treatment delivery, writes Michael...
  4. Nose-to-brain delivery outperforms systemic BBB technologies according to MetP Pharma The pioneering company has published preclinical data that strongly supports the advantages of its proprietary nose-to-brain drug delivery technology compared with systemic...
  5. AstraZeneca strengthens weight management pipeline with CSPC Pharmaceuticals collaboration The pair have signed a strategic collaboration covering eight obesity and type 2 diabetes programmes, including a clinical-ready GLP-1/GIP asset, AI-driven peptide discovery...

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all

Related Content

Manufacturing

Molecular Devices unveils next-generation SpectraMax Multi-Mode Microplate Readers

Honouring a legacy of product line reliability and strength, the SpectraMax Multi-Mode Microplate Readers have been transformed with next-generation innovation to improve research capabilities and provide unparalleled flexibility for a wide range of assays and applications
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development

The case for switching from animal models to organoids in preclinical testing

Mary Duseau, President of Molecular Devices, shares the FDA’s position on the value of human-relevant models in preclinical research and describes how organoids are evolving to become essential tools throughout the drug development process
Manufacturing

Molecular Devices debuts automated microbial colony picking system, QPix FLEX

New platform boosts microbial screening productivity with compact design and near-perfect accuracy
Analysis

Molecular Devices launches automated workcells for ELISA workflows

Showcasing select automated instruments and capabilities at Society for Laboratory Automation and Screening Europe 2022 Conference and Exhibition in Dublin, Ireland
Media

Abcam and Molecular Devices announce strategic collaboration

Abcam, a global innovator in life science reagents and tools, and Molecular Devices, a specialist provider of high-performance bioanalytical measurement solutions for the life science industry, announced a strategic collaboration to develop a wide range of fast and reproducible screening tools for researchers
Subscribe now